Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Viactiv^® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022

Read more at globenewswire.com